Novo Nordisk (NVO) has launched its popular Ozempic drug in India, pricing the 0.25-milligram dose at $24.35 a week, news outlets reported Friday.
The Danish pharmaceutical giant has set monthly prices of the diabetes treatment at 8,800 Indian rupees ($97.24) for the 0.25-mg dose, 10,170 rupees for 0.5-mg, and 11,175 rupees for the 1-mg dose, according to reports. Each pen reportedly contains four weekly doses.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments